Previous Article | Next Article 
Infection and Immunity, June 2001, p. 3663-3669, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3663-3669.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Lipopolysaccharide of Burkholderia
cepacia and Its Unique Character To Stimulate Murine Macrophages
with Relative Lack of Interleukin-1
-Inducing Ability
Hirofumi
Shimomura,1
Motohiro
Matsuura,1,*
Shinji
Saito,1
Yoshikazu
Hirai,1
Yasunori
Isshiki,2 and
Kazuyoshi
Kawahara2
Department of Microbiology, Jichi Medical
School, Tochigi 329-0498,1 and
Department of Bacteriology, The Kitasato Institute, Tokyo
108-8642,2 Japan
Received 27 December 2000/Returned for modification 9 February
2001/Accepted 5 March 2001
 |
ABSTRACT |
Lipopolysaccharide (LPS) of Burkholderia cepacia was
purified by the conventional phenol-water extraction method
(preparation BcLPS-1), followed by enzymatic treatments with DNase,
RNase, trypsin, and proteinase K (preparation BcLPS-2), and finally by deoxycholate-phenol-water extraction (preparation BcLPS-3). Cells of
LPS-hyporesponsive C3H/HeJ mice were activated by both the BcLPS-1 and
the BcLPS-2 preparations but barely activated by BcLPS-3. When
LPS-responsive C3H/HeN mice were used as targets, endotoxic activities
such as lethal toxicity to galactosamine-sensitized mice, mitogenicity
to spleen cells, and activation of macrophages to induce tumor necrosis
factor alpha and interleukin-6 (IL-6) were strongly exhibited even by
highly purified BcLPS-3 at levels comparable to those of the highly
active enterobacterial LPS of Salmonella enterica serovar
Abortus-equi (SaeLPS), used as the control. The ability of BcLPS-3 to
activate murine macrophages for induction of IL-1
was, however, much
weaker than that of SaeLPS. Both accumulation of pro-IL-1
protein
and expression of IL-1
mRNA in macrophages by stimulation with
BcLPS-3 were much weaker than by stimulation with SaeLPS. These results
indicate that LPS of B. cepacia has the potential to play a
role as a pathogenic factor with strong activity comparable to that of
usual enterobacterial LPS, but unlike the latter, this LPS has a
relative lack of ability in the activation of murine macrophages to
induce IL-1
. The lack of IL-1
-inducing ability appears to be
caused by incomplete signal transduction somewhere in the upstream
step(s) of IL-1
gene transcription.
 |
INTRODUCTION |
Burkholderia cepacia is
an aerobic glucose-nonfermenting gram-negative bacillus that possesses
flagella and formerly belonged to the genus Pseudomonas
(37). Bacteria of this species are intrinsically resistant
to many antibiotics and active as opportunistic pathogens in
hospitalized patients and other compromised hosts (8, 26).
Especially among patients with cystic fibrosis, infection by this
organism makes possible the development of serious pneumonia and sepsis
with a high mortality rate, i.e., "cepacia syndrome"
(9). Lipase, protease, extracellular toxic complex, and
lipopolysaccharide (LPS) released from the bacteria have been suggested
as candidates for the virulence factors which cause pathological
changes, such as accumulation of polymorphonuclear leukocytes and
proteinaceous exudate in bronchial and alveolar lumina, injury and
necrosis of bronchial epithelium, and disorganization of alveolar
structure. The specific crucial trigger of the pneumonia and sepsis in
B. cepacia infection, however, remains to be clarified (16, 20, 31, 34, 39).
Among these four candidates, we were interested in LPS, a major
component of the outer membrane in gram-negative bacteria, since it is
assumed to play a central role in the induction of various
pathophysiological responses, such as fever, disseminated intravascular
coagulation, and shock in hosts suffering from gram-negative bacterial
infections (22, 27). LPSs of members of the
Enterobacteriaceae, such as Escherichia coli and
Salmonella, have been investigated intensively as typical
LPSs with high endotoxic activity. Structurally, LPSs are composed of
an O-polysaccharide, an outer core saccharide, an inner core
saccharide, and lipid A regions. The part of the inner core region
adjacent to the lipid A moiety in usual LPS is constructed of one to
three molecules of 3-deoxy-D-manno-octulosonic acid (KDO) and is well conserved among various bacterial species. In
the case of LPS extracted from B. cepacia, KDO was not
detectable by the conventional method (17, 33) but was
detectable after hydrolyzing the LPS with strong acid
(32). This suggests that the KDO portion of the inner core
region in LPS of this organism is replaced by some molecules which
provide acid resistance. Recently, we revealed that B. cepacia LPS contains a
D-glycero-D-talo-2-octulosonic acid (KO) by which KDO is replaced to form a KO-KDO structure in the
inner core region rather than the KDO-KDO structure of usual LPS
(11). As for the biological activities of an LPS with such
a unique structure, the activities of Limulus amoebocyte lysate activation, tumor necrosis factor alpha (TNF-
) induction, and
neutrophil activation have been reported to be stronger than those of
LPS from Pseudomonas aeruginosa, a key opportunistic pathogen isolated from patients with cystic fibrosis, and similar to
those of a typical LPS from E. coli (10, 30,
38). Based on those results, the authors suggested a pathogenic
role of B. cepacia LPS in inflammatory diseases. The LPS
preparations used in those studies were purified only by the
conventional method of phenol-water extraction (36),
without further purification.
In the present study, we aimed to characterize the biological activity
of B. cepacia LPS itself in more detail. We found that preparations of B. cepacia LPS obtained by the phenol-water
extraction method are not sufficiently purified to be free of some
trace contaminants which induce the response of LPS-hyporesponsive
cells of C3H/HeJ mice. We also found that introduction of the
deoxycholate (DOC)-phenol-water extraction method (18) in
a further purification step was effective in removing such
contaminants. This highly purified B. cepacia LPS indicated
strong biological activity, comparable to that of a typical LPS of
Salmonella enterica serovar Abortus-equi (SaeLPS) but with
the exception of weak induction of interleukin-1-
(IL-1
) from
murine macrophages.
 |
MATERIALS AND METHODS |
Mice and cell culture.
C3H/HeN (LPS-responsive) and
C3H/HeJ (LPS-hyporesponsive) mice were purchased from Clea Japan, Inc.
(Tokyo, Japan), and used at ages of 8 to 14 weeks. For cell culture,
RPMI 1640 medium (Flow Laboratories, Inc., Rockville, Md.) supplemented
with 10 mM HEPES, 2 mM L-glutamine, 100 U of penicillin per
ml, 100 µg of streptomycin per ml, 0.2% NaHCO3, and 2.5 to 10% heat-inactivated fetal calf serum (FCS-RPMI) was used. All
cells were cultured in a humidified chamber at 37°C with 5%
CO2. Murine peritoneal macrophages were prepared by
conventional method. Peritoneal exudate cells taken from mice that had
received 2 ml of thioglycolate broth (Difco Laboratories, Detroit,
Mich.) intraperitoneally 4 days in advance were washed and resuspended
in 5% FCS-RPMI. A 0.5-ml aliquot of the cell suspension
(106/ml) was dispensed into each well of a 48-well culture
plate (Sumitomo Bakelite Co. Ltd., Tokyo, Japan) and cultured for
3 h. Nonadherent cells were washed off, and the remaining adherent
cells were used as macrophages. A murine macrophage-like cell line, RAW
264.7, obtained from the American Type Culture Collection (ATCC)
(Manassas, Va.) and maintained in our laboratory was also used.
LPS preparations.
B. cepacia GIFU 645 used in the
present study is a type strain of B. cepacia, the same
strain as ATCC 25416 or NCTC 10743, and belongs to genomovar I. The
bacterial cells obtained by culture with nutrient broth no. 2 (Oxoid
Ltd., Basingstoke, United Kingdom) at 35°C for 24 h were heat
killed (100°C for 30 min), and LPS was extracted in the aqueous phase
by the conventional phenol-water extraction method (36).
The aqueous phase was centrifuged to obtain LPS as precipitate; this
first LPS preparation was referred to as BcLPS-1. For further
purification, BcLPS-1 was treated with 1 µg of DNase/ml plus 1 µg
of RNase/ml (both enzymes were from bovine pancreas; Sigma Chemical
Co., St. Louis, Mo.) at 30°C for 90 min at pH 7.5, followed by the
addition of 1 µg of trypsin/ml from porcine pancreas (Wako
Pure-Chemical Industries Ltd., Osaka, Japan) and incubation at 30°C
for 90 min. Finally, 1 µg of proteinase K/ml from fungi (Wako Pure
Chemical Industries Ltd.) was added and incubated for an additional 90 min. After these enzymatic treatments, the solution was dialyzed
against distilled water and lyophilized to obtain the second
preparation, BcLPS-2. This preparation was then treated with 45%
phenol containing triethylamine and sodium DOC, and LPS extracted in
the aqueous phase was precipitated with ethanol by the DOC-phenol-water
extraction method (18) to obtain the third preparation,
BcLPS-3. These three preparations were examined for biological
activities. SaeLPS, purified as described elsewhere (7),
was kindly donated by C. Galanos (Max-Planck-Institut für
Immunbiologie, Freiburg, Germany) and used as a control enterobacterial LPS.
Lethal toxicity.
Lethal toxicity of LPS preparations to
galactosamine (GalN)-sensitized mice was examined according to the
established method (6). Groups of 6 to 10 mice were
administered GalN (Sigma Chemical Co.) intraperitoneally at 18 mg/mouse
and LPS preparations intravenously at doses of serial 10-fold
dilutions. Survival of the mice was observed for 3 days, and results
were expressed as 50% lethal doses calculated by the method of
Kärber (12).
Mitogenic activity.
Mouse spleen cells suspended in 10%
FCS-RPMI were plated on a 96-well round-bottom microplate (Nunc,
Roskilde, Denmark) at a density of 4 × 105 cells/well
and cultured in the presence of LPS preparations for 48 h. The
culture was pulse-labeled with 1 µCi of [3H]thymidine
(ICN Biomedicals, Inc., Irvine, Calif.) per well for the last 4 h,
and radioactivity (counts per minute) incorporated into the cells was
measured by a TopCount microplate scintillation counter (Packard Japan
Co. Ltd., Tokyo, Japan). Results were expressed as the stimulation
index, which is the ratio of counts per minute in a test sample to that
in a negative control sample (absence of stimulants).
Macrophage stimulation and cytokine assay.
Murine peritoneal
macrophages were cultured in the presence or absence of LPS
preparations with 5% FCS-RPMI. Culture supernatants obtained at 4 h were assayed for activity of TNF-
, and those obtained at 48 h
were assayed for activity of IL-6 and for amount of IL-1
. In some
experiments, adherent RAW 264.7 cells were also used as murine
macrophages in a manner similar to peritoneal macrophages.
Activity of TNF-
was determined by a cytotoxic assay against
actinomycin D-treated L929 cells (28). Briefly, L929 cells were cultured with 5% FCS-RPMI in a 96-well flat-bottom culture plate
(Nunc) for 3 h, and actinomycin D (Sigma Chemical Co.) was added
at a final concentration of 1 µg/ml with serial dilutions of test
samples. Viable cells in the overnight culture were stained with
crystal violet, and absorbance of the blue color extracted with 30%
acetic acid was measured at 540 nm by a Biomek 1000 spectrophotometer (Beckman Instruments, Palo Alto, Calif.). The activity of TNF-
(in
units per milliliter) was calculated from the dilution factor of test
samples necessary for 50% cell lysis, with correction by an internal
standard of recombinant human TNF-
in each assay.
IL-6 activity was determined by a proliferation assay of IL-6-dependent
mouse hybridoma MH60.BSF2 cells (19), a kind gift from N. Nishimoto of Osaka University (Osaka, Japan). Briefly, the cells were
cultured for 3 days in a 2.5% FCS-RPMI supplemented with 5 × 10
5 M 2-mercaptoethanol in a 96-well flat-bottom culture
plate (Nunc), and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
(Sigma Chemical Co.) was added for the last 4 h of the culture for
formation of formazan blue crystals by viable cells (23). The supernatant was removed, and precipitated formazan crystals were
dissolved with isopropanol solution containing 5% formic acid to
measure the absorbance at 540 nm. IL-6 activity (in units per
milliliter) was calculated from the dilution factor of test samples
required to induce 50% cell growth, with correction by an internal
standard of recombinant human IL-6 in each assay.
The amount of IL-1
was determined by a specific sandwich
enzyme-linked immunosorbent assay. A 96-well EIA/RTA plate (Costar, Cambridge, Mass.) was coated with a purified goat antibody to mouse
IL-1
(R&D Systems, Minneapolis, Minn.). To the plate incubated with
test samples and standard solutions (mouse IL-1
enzyme-linked immunosorbent assay standard; Endogen, Woburn, Mass.), biotinylated monoclonal antibody against mouse IL-1
(Endogen) was added as a
detection antibody. Streptavidin-horseradish peroxidase conjugate (PharMingen, San Diego, Calif.) was added for the development of an
enzyme reaction with a substrate solution of TMBZ (0.01% 3,3',5,5'-tetramethylbenzidine and 0.03% H2O2
in 0.11 M acetate buffer, pH 5.5). The color reaction was stopped by
adding 1.8 M H2SO4, and absorbance was measured
at 450 nm. Quantification of IL-1
(in picograms per milliliter) was
performed based on a standard IL-1
curve in each assay.
Detection of pro-IL-1
.
Macrophages were stimulated with
LPS for 20 to 24 h, and culture supernatant was removed. The cells
were washed and lysed in lysis buffer (1% Triton X-100, 20 mM
Tris-HCl, [pH 8.0], 137 mM NaCl, 10% glycerol, 1 mM
Na3VO4, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 20 µM leupeptin, 0.15 U of aprotinin per ml) by three freeze-and-thaw cycles. The cell lysate obtained after removal of
insoluble materials by centrifugation was adjusted for protein content
at 30 µg and separated on sodium dodecyl sulfate-10% polyacrylamide gel according to the method of Laemmli (15). Proteins
separated on the running gel were transferred to a polyvinylidene
difluoride membrane (Nihon Millipore Ltd., Tokyo, Japan), and
pro-IL-1
protein (>30 kDa) was analyzed using biotinylated
anti-mouse IL-1
monoclonal antibody (Endogen) and ECL Western
blotting reagent (Amersham Life Science, Amersham, United Kingdom)
according to the manufacturers'-instructions.
Detection of IL-1
mRNA by reverse transcribed (RT)-PCR.
Total RNA of macrophages stimulated with LPS for 6 h was extracted
by the acid guanidinium thiocyanate-phenol-chloroform method (4). Synthesis of cDNA from the total RNA (1 µg) was
performed by priming with 200 ng of random hexamer, 1.25 mM
deoxynucleoside triphosphate, and 60 U of SuperScript II reverse
transcriptase (Gibco BRL Life Technologies, Inc., Gaithersburg, Md.) at
38°C for 1 h. The sequences of the primers used in PCR for mouse
IL-1
were 5'-GCAACTGTTCCTGAACTCAA-3' and
5'-GACGTGATGTCCGAGGCTC-3', and those for mouse
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were
5'-CCTCAACTACATGGTCTA-3' and
5'-TGAAACCGTAACACCTTCC-3'. PCR was carried out at 94°C for
1 min, 63°C for 1 min, and 72°C for 2 min as 1 cycle, and 25 and 27 cycles were performed for IL-1
and GAPDH, respectively. The PCR
products were analyzed after electrophoresis on a 2% agarose gel
by ethidium bromide staining.
 |
RESULTS |
Mitogenic activity of BcLPS preparations to mouse spleen
cells.
All three preparations of BcLPS exhibited strong mitogenic
activity to C3H/HeN spleen cells in a manner similar to that of the
control SaeLPS (Fig. 1A); i.e.,
significant activities detected at 0.05 µg/ml increased dose
dependently up to the highest concentration tested (50 µg/ml).
Mitogenic activity to spleen cells of C3H/HeJ mice, which are
hyporesponsive to LPS due to defective functional Toll-like receptor 4 (TLR4) production (25), was then examined. As shown in
Fig. 1B, BcLPS-1 and -2 exhibited significant mitogenic activity to
C3H/HeJ spleen cells at concentrations over 0.5 µg/ml. In contrast,
the activity of BcLPS-3 was much weaker and only marginal activity was
detectable at the highest concentration tested (50 µg/ml), just like
activity of the control SaeLPS. These results indicate that BcLPS-3
inevitably requires TLR4 as well as purified usual LPS for the
transduction of mitogenic signals, while BcLPS-1 and -2 have a
contaminating factor(s) which induces mechanisms other than the TLR4
pathway for the transduction of signals.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Mitogenic activity of BcLPS preparations to murine
spleen cells. Spleen cells of C3H/HeN (A) and C3H/HeJ (B) mice were
cultured with BcLPS-1 ( ), BcLPS-2 ( ), BcLPS-3 ( ), or the
control SaeLPS ( ) at the indicated concentrations for 48 h. The
cells were pulse-labeled with [3H]thymidine for the last
4 h of culture, and radioactivity (counts per minute) in the
harvested cells was measured. Results are expressed as a stimulation
index, which is the ratio of count per minute in a test sample to that
in a negative control (absence of stimulants). Data are means ± standard errors of the means for triplicate samples. A representative
result obtained from three independent experiments is shown.
|
|
Activity of BcLPS preparations to induce TNF-
production from
murine peritoneal macrophages.
Potency of the LPS preparations to
activate murine peritoneal macrophages for induction of TNF-
was
then investigated. When the macrophages of C3H/HeN mice were used as
target cells, all three BcLPS preparations exhibited strong, similar
activities and induced TNF-
production at concentrations over 1 ng/ml, as did the control SaeLPS, although the amounts of induced
TNF-
were somewhat smaller than those of the control SaeLPS (Fig.
2A). In the case of C3H/HeJ macrophages
used as target cells, BcLPS-1 and -2 induced significant amounts of
TNF-
at concentrations over 100 ng/ml, while BcLPS-3 and the control
SaeLPS induced no detectable amounts of TNF-
even at the highest
concentration tested (10 µg/ml) (Fig. 2B).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Induction of TNF- from murine peritoneal macrophages
by BcLPS preparations. Peritoneal macrophages obtained from C3H/HeN (A)
and C3H/HeJ (B) mice were cultured in the presence of BcLPS-1 ( ),
BcLPS-2 ( ), BcLPS-3 ( ), or the control SaeLPS ( ) at the
indicated concentrations. Culture supernatants obtained at 4 h
after LPS stimulation were assayed for determination of TNF-
induction. Data are means ± standard errors of the means for
triplicate samples. A representative result obtained from three
independent experiments is shown.
|
|
These results, together with those of the mitogenic activity shown in
Fig. 1, indicate that BcLPS-1 and -2 contain some minor contaminants
which play a role in activating TLR4-deficient C3H/HeJ cells and that
such contaminants have been removed in the BcLPS-3 preparation. In the
following experiments, BcLPS-3 was used as the purified BcLPS preparation.
Lethal toxicity of BcLPS-3 to GalN-sensitized mice.
Groups of
6 to 10 mice aged 11 to 14 weeks were given GalN (18 mg/mouse)
intraperitoneally and then LPS intravenously at doses of serial 10-fold
dilutions. Survival of the mice was observed for 3 days to estimate the
lethal toxicity of LPS. The 50% lethal dose of BcLPS-3 to C3H/HeN mice
was calculated to be 3 ng/mouse, which was somewhat lower than that of
the control SaeLPS, 10 ng/mouse. This indicates that the lethal
toxicity of BcLPS-3 to C3H/HeN mice is very strong, comparable to or
somewhat stronger than that of the control SaeLPS. In contrast, BcLPS-3
as well as the control LPS exhibited no lethal toxicity to C3H/HeJ mice
even at the highest dose tested (10,000 ng/mouse). These results
indicate that activation of signaling pathways through TLR4 is
indispensable for expression of the lethal toxicity of BcLPS-3 as well
as usual LPS.
Potency of BcLPS-3 to activate murine macrophages for induction of
cytokines.
Peritoneal macrophages of C3H/HeN mice were stimulated
with BcLPS-3, and production of cytokines TNF-
, IL-6, and IL-1
in the culture supernatant was measured. Significant amounts of TNF-
and IL-6 were produced upon stimulation with BcLPS-3 at concentrations over 1 ng/ml, in a manner similar to that of the control LPS, although
the amounts of cytokines produced by BcLPS-3 were somewhat lower than
those produced by the control LPS (Fig. 3A and
B). In contrast, BcLPS-3 exhibited weak
potency in the induction of IL-1
while the control SaeLPS exhibited
strong potency in induction of this cytokine (Fig. 3C). Only small
amounts of IL-1
were detected upon stimulation with BcLPS-3 at 10 and 100 ng/ml. However, the control LPS induced significant amounts of
IL-1
at concentrations over 1 ng/ml, similar to the induction of the
other two cytokines.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Stimulation of C3H/HeN peritoneal macrophages with
BcLPS-3 to induce cytokines. Peritoneal macrophages obtained from
C3H/HeN mice were cultured in the presence of BcLPS-3 ( ) or the
control SaeLPS ( ) at the indicated concentrations. Culture
supernatants recovered at 4 h after LPS stimulation were assayed
for determination of TNF- induction (A), and those recovered at
48 h were assayed for determination of IL-6 (B) and IL-1 (C)
induction Data are means ± standard errors of the means for
triplicate samples. A representative result obtained from three
independent experiments is shown.
|
|
A murine macrophage cell line, RAW 264.7, was then used to further
investigate the potency of BcLPS-3 to induce those cytokines. As shown
in Fig. 4A and B, large amounts (over
1,000 U/ml) of TNF-
and IL-6 were produced by RAW 264.7 cells upon
stimulation with BcLPS-3 at concentrations over 10 ng/ml, although a
concentration about 1 order of magnitude higher than that of the
control LPS was required to induce similar amounts of these cytokines.
Only marginal amounts of IL-1
were produced by RAW 264.7 cells upon stimulation with BcLPS-3 at 100 ng/ml, while significantly larger amounts were induced by the control LPS at concentrations over 1 ng/ml,
similar to the induction of the other two cytokines (Fig. 4C).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Stimulation of the murine macrophage cell line RAW 264.7 with BcLPS-3 to induce cytokines. RAW 264.7 cells were cultured in the
presence of BcLPS-3 ( ) or the control SaeLPS ( ) at the indicated
concentrations. Culture supernatants recovered at 48 h after LPS
stimulation were assayed for determination of TNF- (A), IL-6 (B),
and IL-1 (C) induction. Data are means ± standard errors of
the means for triplicate samples. A representative result obtained from
three independent experiments is shown.
|
|
These results reveal the unique character of BcLPS; i.e., it has a much
reduced ability to induce IL-1
, while it has abilities comparable to
those of usual enterobacterial LPS for other activities, such as
induction of TNF-
and IL-6, mitogenic activity, and lethal toxicity.
Production of pro-IL-1
in murine macrophages upon stimulation
with BcLPS-3.
We then investigated the underlying mechanisms in
the weak ability of BcLPS to induce IL-1
. It was clarified that
mature IL-1
is released from cells after proteolytic cleavage of
precursor pro-IL-1
by the action of IL-1
-converting enzyme
(2, 14). After LPS stimulation of peritoneal macrophages
of C3H/HeN mice, the culture supernatant was removed and the cells were
washed. Accumulation of pro-IL-1
(>30 kDa) in the cell lysate was
detected by immunoblotting analysis. Low-molecular-weight bands
corresponding to mature IL-1
(<20 kDa) were scarcely detected in
these lysates of washed cells, as was shown in numerous previous
reports. High-density bands corresponding to pro-IL-1
protein were
detected in the lysates upon with stimulation of the control LPS at
concentrations over 1 ng/ml, while only low-density bands were
detectable in the lysates upon stimulation of BcLPS-3 at 10 and 100 ng/ml as shown in Fig. 5. These results
correlate well with the results of IL-1
-inducing potency shown in
Fig. 3C and indicate that, as early as the step of intracellular
production of pro-IL-1
protein, signals coming from BcLPS-3
stimulation were hardly transduced.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 5.
Production of pro-IL-1 in murine peritoneal
macrophages upon LPS stimulation. Peritoneal macrophages of C3H/HeN
mice were stimulated for 20 to 24 h with the indicated
concentrations of SaeLPS or BcLPS-3. After removal of the culture
supernatant, cells were washed and lysed by three freeze-and-thaw
cycles in the lysis buffer. The cell lysates containing 30 µg of
total proteins were subjected to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis. Proteins on the gel were transferred to a
polyvinylidene difluoride membrane, and pro-IL-1 (>30 kDa) was
detected by immunoblotting analysis with biotin-labeled anti-mouse
IL-1 monoclonal antibody.
|
|
Expression of IL-1
mRNA in murine macrophages upon stimulation
with BcLPS-3.
As one of the upstream processes of pro-IL-1
synthesis, expression of IL-1
mRNA in those cells was then
investigated by the RT-PCR method. As shown in Fig.
6, the bands originating from IL-1
mRNA were clearly detected in the cells stimulated with SaeLPS at
concentrations over 1 ng/ml, while only weak bands were detected in
cells stimulated with BcLPS-3 at the corresponding concentrations.
These results suggest that signals for IL-1
production upon
stimulation with BcLPS-3 are down-regulated before the step of IL-1
gene transcription.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6.
Expression of IL-1 mRNA in murine peritoneal
macrophages upon LPS stimulation. Peritoneal macrophages of C3H/HeN
mice were exposed to the indicated concentrations of SaeLPS or BcLPS-3
for 6 h. Total RNA extracted from the cells was analyzed for mRNA
expression of IL-1 and control GAPDH by RT-PCR. PCR products of
IL-1 and GAPDH obtained by 25 and 27 cycles, respectively, were
subjected to agarose gel electrophoresis and visualized by ethidium
bromide staining.
|
|
 |
DISCUSSION |
In the present study, we show that preparations of B. cepacia LPS purified by phenol-water extraction, (BcLPS-1) and
further by enzymatic treatments (BcLPS-2) have the potency to activate the cells of LPS-hyporesponsive C3H/HeJ mice (Fig. 1 and 2). Such potency was reduced to negligible levels in the preparation of BcLPS-3
obtained after further purification by the DOC-phenol-water extraction
method (18). Since this method was developed for the
elimination of trace endotoxin protein from LPS preparations, BcLPS-1
and -2 in this study were assumed to contain trace amounts of proteins,
such as endotoxin protein (35) and lipid A-associated protein (21), that induce the response of
LPS-hyporesponsive cells even with very slight contamination of LPS. In
previous reports of biological activities of B. cepacia LPS
(10, 30, 38), LPS preparations used were obtained by the
phenol-water extraction method without further purification and their
potency to activate C3H/HeJ cells was not tested. Those LPS
preparations were purified to no further level than that of BcLPS-1,
suggesting that they probably were contaminated with trace amounts of
proteins, such as endotoxin protein. When using such preparations, it
is problematic to assign a biological activity to LPS itself free from
the effect of such protein contaminants. Highly purified preparations
of B. cepacia LPS, such as BcLPS-3, have not been used for
biological investigations before the present study.
It is important to clarify the biological activity of B. cepacia LPS itself for a better understanding of the role of LPS in diseases with B. cepacia infection. We used BcLPS-3 for
biological investigations and found that it has strong endotoxic
activity, comparable to that of a representative enterobacterial LPS
(SaeLPS) in activities such as lethal toxicity to GalN-sensitized mice, mitogenic activity, and macrophage activation activities for induction of TNF-
and IL-6. These results suggest that B. cepacia
LPS, independently of contaminating proteins, has the ability to play a
pathogenic role in the sepsis-like cepacia syndrome that is as strong
as those of highly active enterobacterial LPSs. The above-mentioned
B. cepacia LPS preparations in previous studies (10,
30, 38) were obtained from different strains, and all of them
were reported to exhibits strong endotoxic activity, comparable to that
of the control enterobacterial LPS. Considering the results of the
present study with those of the previous reports, LPS of B. cepacia through a wide variety of strains may have potential as a
pathogenic factor with strong endotoxic activity, although biological
studies using more preparations of purified B. cepacia LPS
without reactivity to HeJ cells are required to confirm this potential.
It is interesting that B. cepacia LPS, unlike the
enterobacterial LPS, exhibited only slight activity in the induction of IL-1
, while it showed strong activity, comparable to that of the
enterobacterial LPS, in the induction of TNF-
and IL-6, as well as
in mitogenic activity and lethal toxicity. The selective lack of
IL-1
-inducing ability observed in B. cepacia LPS has not
been reported in biological studies of any other LPS. A typical chemical characteristic of B. cepacia LPS revealed by
chemical analysis of LPS obtained from the strain used in the present
study is the unusual presence of KO, instead of the usual KDO, as a side chain of KDO linking the lipid A backbone and polysaccharide chain
of LPS (11). The presence of this KO-KDO structure in the
inner core region is suggested to form an acid-resistant linkage of
lipid A to the polysaccharide chain. This unique chemical structure, however, does not seem to be directly related to the expression of the
above-mentioned unique biological character of the LPS, since similarly
purified LPS of Burkholderia pseudomallei exhibited IL-1
-inducing activity comparable to that of enterobacterial LPS
(data not shown) despite possession of the KO-KDO structure in its
inner core region. To elucidate the part of the chemical structure in
B. cepacia LPS responsible for the expression of this unique
biological activity, further chemical studies, including precise
determination of the entire structure of the LPS, are necessary.
Recently, some reports have indicated that nitric oxide (NO) has the
potency to prevent induction of IL-1
(13, 24, 29). In
the experiments on macrophage activation in the present study, we
measured induction of NO in addition to the cytokines and found that
BcLPS-3 induced no larger amounts of NO than the control SaeLPS did
(data not shown). This indicates that selective inhibition of IL-1
induction in a feedback fashion by excessive production of NO is not
the action mechanism of the B. cepacia LPS. Furthermore, prevention of IL-1
induction by NO was indicated to be caused by
inhibition of IL-1
-converting enzyme activity, which catalyzes the
processing of pro-IL-1
to form active IL-1
and release it to the
outside of the cells (13). In such a case, large amounts of pro-IL-1
protein are accumulated in the cells and small amounts of IL-1
are released from the cells. In the present study, only small amounts of pro-IL-1
were detected in the cell lysate obtained after stimulation with B. cepacia LPS, in good correlation
with the amounts of extracellular IL-1
(Fig. 3 and 5). These results indicate that signal transduction for IL-1
production in response to
the B. cepacia LPS is down-regulated in some steps before
pro-IL-1
synthesis is completed.
Selective inhibition of IL-1
gene expression by gamma interferon
(IFN-
) in activated RAW 264.7 cells has been reported
(5). In the experiments, IFN-
was exogenously added to
a culture of RAW 264.7 cells stimulated with LPS plus TNF-
, and a
suppressive effect of IFN-
on IL-1
gene expression was shown. In
our experiments using RAW 264.7 cells (Fig. 4), no detectable amounts
of IFN-
were present in the culture supernatant upon stimulation
with either BcLPS-3 or SaeLPS (data not shown), indicating no
participation of IFN-
in the mechanism of the weak IL-1
induction
by the B. cepacia LPS.
Expression of IL-1
mRNA in murine macrophages by stimulation with
BcLPS-3 was clearly weaker than that with SaeLPS (Fig. 6), suggesting
that the lack of IL-1
induction by B. cepacia LPS is
caused by down-regulation at the transcriptional step of the IL-1
gene or the upstream signaling pathways. Stimulation of macrophages by
LPS induces activation of a number of different second-messenger
pathways, including the mitogen-activated protein kinase and NF-
B
cascades, which activate nuclear transcription factors to induce their
DNA-binding ability to regulatory sequences in promoter regions of
target genes such as cytokine genes. Although virtually nothing is
known about the signaling pathways that affect the regulation of
LPS-induced IL-1
gene transcription, important roles of p38
mitogen-activated protein kinase through activation of CCAATT/enhancer
binding protein (C/EBP)/NFIL-6 transcription factors (1)
and of the newly identified mitogen- and stress-activated kinase-1
through activation of cyclic AMP-responsive element-binding protein
(CREB) (3) have recently been indicated. B. cepacia LPS may have incomplete potency to transduce some parts of
the signals leading to activation of such factors as C/EBP/NFIL-6 and
CREB, which are essential for gene transcription of IL-1
but not for
those of TNF-
, IL-6, and some other LPS mediators, and may be a
useful tool for investigation of the LPS signals selectively required
for IL-1
induction.
In the present study, we have demonstrated that preparations of
B. cepacia LPS at the purification levels of the
conventional phenol-water extraction method and further enzymatic
treatments still contain trace amounts of contaminants which exhibit
endotoxin protein-like activity and that introduction of the
DOC-phenol-water extraction method in a further purification step is
effective in eliminating such contaminants. By using such a highly
purified B. cepacia LPS, the strong endotoxic potency of
this LPS, comparable to that of highly active enterobacterial LPS, was
confirmed, and the unique characteristic of this LPS, a relative lack
of ability to induce IL-1
from murine macrophages, was found. The
weak ability of this LPS to induce IL-1
was suggested to be caused
by incomplete signal transduction somewhere in the upstream step(s) of
IL-1
gene transcription.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Jichi Medical School, 3311-1 Yakushiji,
Minamikawachi-machi, Tochigi 329-0498, Japan. Phone: 81-285-58-7332. Fax: 81-285-44-1175. E-mail: mmatsuur{at}jichi.ac.jp.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Baldassare, J. J.,
Y. Bi, and C. J. Bellone.
1999.
The role of p38 mitogen-activated protein kinase in IL-1 transcription.
J. Immunol.
162:5367-5373[Abstract/Free Full Text].
|
| 2.
|
Black, R. A.,
S. R. Kronheim,
M. Cantrell,
M. C. Deeley,
C. J. March,
K. S. Prickett,
J. Wignall,
P. J. Conlon,
D. Cosman,
T. P. Hopp, and D. Y. Mochizuki.
1988.
Generation of biologically active interleukin-1 by proteolytic cleavage of the inactive precursor.
J. Biol. Chem.
263:9437-9442[Abstract/Free Full Text].
|
| 3.
|
Caivano, M., and P. Cohen.
2000.
Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 in RAW264 macrophages.
J. Immunol.
164:3018-3025[Abstract/Free Full Text].
|
| 4.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 5.
|
Chujor, C. S. N.,
L. Klein, and C. Lam.
1996.
Selective inhibition of interleukin-1 gene expression in activated RAW 264.7 macrophages by interferon- .
Eur. J. Immunol.
26:1253-1259[Medline].
|
| 6.
|
Galanos, C.,
M. A. Freudenberg, and W. Reutter.
1979.
Galactosamine-induced sensitization to the lethal effects of endotoxin.
Proc. Natl. Acad. Sci. USA
76:5939-5943[Abstract/Free Full Text].
|
| 7.
|
Galanos, C.,
O. Lüderitz, and O. Westphal.
1979.
Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-pyrexal).
Zentbl. Bakteriol. Hyg. I Abt. 1 Orig. A
243:226-244.
|
| 8.
|
Golgman, D. A., and J. D. Klinger.
1986.
Pseudomonas cepacia biology, mechanisms of virulence, epidemiology.
J. Pediatr.
108:806-812[CrossRef][Medline].
|
| 9.
|
Govan, J. R. W., and J. W. Nelson.
1992.
Microbiology of lung infection in cystic fibrosis.
Br. Med. Bull.
48:912-930[Abstract/Free Full Text].
|
| 10.
|
Hughes, J. E.,
J. Stewart,
G. R. Barclay, and J. R. W. Govan.
1997.
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.
Infect. Immun.
65:4281-4287[Abstract].
|
| 11.
|
Isshiki, Y.,
K. Kawahara, and U. Zähringer.
1998.
Isolation and characterisation of disodium (4-amino-4-deoxy- -L-arabinopyranosyl)-(1 8)-(D-glycero- -D-talo-oct-2-ulopyranosylonate)-(2 4)-(methyl-3-deoxy-D-manno-oct-2-ulopyranoside)onate from the lipopolysaccharide of Burkholderia cepacia.
Carbohydr. Res.
313:21-27[CrossRef][Medline].
|
| 12.
|
Kärber, G.
1931.
Beitrag zur kollektiven behandlung pharmakologischer reihenversuche.
Arch. Exp. Pathol. Pharmakol.
162:480-487[CrossRef].
|
| 13.
|
Kim, Y. M.,
R. V. Talanian,
J. Li, and T. R. Billiar.
1988.
Nitric oxide prevents IL-1 and IFN- -inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1 -converting enzyme).
J. Immunol.
161:4122-4128[Abstract/Free Full Text].
|
| 14.
|
Kostura, M. J.,
M. J. Tocci,
G. Limjuco,
J. Chin,
P. Cameron,
A. G. Hillman,
N. A. Chartrain, and J. A. Schmidt.
1989.
Identification of a monocyte specific pre-interleukin 1 convertase activity.
Proc. Natl. Acad. Sci. USA
86:5227-5231[Abstract/Free Full Text].
|
| 15.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 16.
|
Lonon, M. K.,
D. E. Woods, and D. C. Straus.
1992.
The effects of purified 25 kDa lipase from a clinical isolate of Pseudomonas cepacia in the lungs of rats.
Curr. Microbiol.
25:89-93[CrossRef][Medline].
|
| 17.
|
Manniello, J. M.,
H. Heymann, and F. W. Adair.
1979.
Isolation of atypical lipopolysaccharides from purified cell walls of Pseudomonas cepacia.
J. Gen. Microbiol.
112:397-400[Medline].
|
| 18.
|
Manthey, C. L., and S. N. Vogel.
1994.
Elimination of trace endotoxin protein from rough chemotype LPS.
J. Endotoxin Res.
1:84-91.
|
| 19.
|
Matsuda, T.,
T. Hirano, and T. Kishimoto.
1987.
Establishment of an interleukin 6 (IL-6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies.
Eur. J. Immunol.
18:951-956.
|
| 20.
|
McKevitt, A. I.,
S. Bajaksouzian,
J. D. Klinger, and D. E. Woods.
1989.
Purification and characterization of an extracellular protease from Pseudomonas cepacia.
Infect. Immun.
57:771-778[Abstract/Free Full Text].
|
| 21.
|
Morrison, D. C.,
S. J. Betz, and D. M. Jacobs.
1976.
Isolation of a lipid A bound polypeptide responsible for `LPS-initiated' mitogenesis of C3H/HeJ spleen cells.
J. Exp. Med.
144:840-846[Abstract/Free Full Text].
|
| 22.
|
Morrison, D. C., and J. L. Ryan.
1987.
Endotoxins and disease mechanisms.
Annu. Rev. Med.
38:417-432[Medline].
|
| 23.
|
Mosman, T.
1983.
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay.
J. Immunol. Methods.
65:55-63[CrossRef][Medline].
|
| 24.
|
Obermeier, F.,
V. Gross,
J. Schölmerich, and W. Falk.
1999.
Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide.
J. Leukoc. Biol.
66:829-836[Abstract].
|
| 25.
|
Poltorak, A.,
X. He,
I. Smirnova,
M.-Y. Liu,
C. Van Huffel,
X. Du,
D. Bridwell,
E. Alejos,
M. Silva,
C. Galanos,
C. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene.
Science
282:2085-2088[Abstract/Free Full Text].
|
| 26.
|
Prince, A.
1986.
Antibiotic resistance of Pseudomonas species.
J. Pediatr.
108:830-834[CrossRef][Medline].
|
| 27.
|
Rietschel, E. T.,
T. Kirikae,
F. U. Schade,
U. Mamat,
G. Schmidt,
H. Loppnow,
A. J. Ulmer,
U. Zahringer,
U. Seydel,
F. D. Padova,
M. Schreier, and H. Brade.
1994.
Bacterial endotoxin: molecular relationships of structure to activity and function.
FASEB J.
8:217-225[Abstract].
|
| 28.
|
Ruff, M. R., and G. E. Gilfford.
1980.
Purification and physiological characterization of rabbit tumor necrosis factor.
J. Immunol.
125:1671-1677[Abstract].
|
| 29.
|
Schroeder, R. A.,
C. Cai, and P. C. Kuo.
1999.
Endotoxin-mediated nitric oxide synthesis inhibits IL-1 gene transcription in ANA-1 murine macrophages.
Am. J. Physiol.
277:C523-C530[Abstract/Free Full Text].
|
| 30.
|
Shaw, D.,
I. R. Poxton, and J. R. W. Govan.
1995.
Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide.
Immunol. Med. Microbiol.
11:99-106[CrossRef].
|
| 31.
|
Straus, D. C.,
M. K. Lonon, and J. C. Hutson.
1992.
Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase.
J. Med. Microbiol.
37:335-340[Abstract].
|
| 32.
|
Straus, D. C.,
M. K. Lonon,
D. E. Woods, and C. W. Garner.
1990.
3-Deoxy-D-manno-2-octulosonic acid in the lipopolysaccharide of various strains of Pseudomonas cepacia.
J. Med. Microbiol.
33:265-269[Abstract].
|
| 33.
|
Straus, D. C.,
M. K. Lonon,
D. E. Woods, and C. W. Garner.
1989.
Production of an extracellular toxic complex by various strains of Pseudomonas cepacia.
J. Med. Microbiol.
30:17-22[Abstract].
|
| 34.
|
Straus, D. C.,
D. E. Woods,
M. K. Lonon, and C. W. Garner.
1988.
The importance of extracellular antigens in Pseudomonas cepacia infection.
J. Med. Microbiol.
26:269-280[Abstract].
|
| 35.
|
Sultzer, B. M., and G. W. Goodman.
1976.
Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ.lymphocytes.
J. Exp. Med.
144:821-827[Abstract/Free Full Text].
|
| 36.
|
Westphal, O.,
O. Lüderitz, and F. Bister.
1952.
Über die Extraction von Bakterien mit Phenol/Wasser.
Z. Naturforsch. Teil B
7:148-155.
|
| 37.
|
Yabuuchi, E.,
Y. Kosako,
H. Oyaizu,
I. Yano,
H. Hotta,
Y. Hashimoto,
T. Ezaki, and M. Arakawa.
1992.
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.
Microbiol. Immunol.
36:1251-1275[Medline].
|
| 38.
|
Zughaier, S. M.,
H. C. Ryley, and S. K. Jackson.
1999.
Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes.
Infect. Immun.
67:1505-1507[Abstract/Free Full Text].
|
| 39.
|
Zughaier, S. M.,
H. C. Ryley, and S. K. Jackson.
1999.
A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion.
Infect. Immun.
67:908-913[Abstract/Free Full Text].
|
Infection and Immunity, June 2001, p. 3663-3669, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3663-3669.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
De Soyza, A., Silipo, A., Lanzetta, R., Govan, J. R., Molinaro, A.
(2008). Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides. Innate Immunity
14: 127-144
[Abstract]
-
Tang, X., Marciano, D. L., Leeman, S. E., Amar, S.
(2005). LPS induces the interaction of a transcription factor, LPS-induced TNF-{alpha} factor, and STAT6(B) with effects on multiple cytokines. Proc. Natl. Acad. Sci. USA
102: 5132-5137
[Abstract]
[Full Text]
-
Shimomura, H., Matsuura, M., Saito, S., Hirai, Y., Isshiki, Y., Kawahara, K.
(2003). Unusual Interaction of a Lipopolysaccharide Isolated from Burkholderia cepacia with Polymyxin B. Infect. Immun.
71: 5225-5230
[Abstract]
[Full Text]
-
Vinion-Dubiel, A. D., Goldberg, J. B.
(2003). Review: Lipopolysaccharide of Burkholderia cepacia complex. Innate Immunity
9: 201-213
[Abstract]
-
Tomich, M., Griffith, A., Herfst, C. A., Burns, J. L., Mohr, C. D.
(2003). Attenuated Virulence of a Burkholderia cepacia Type III Secretion Mutant in a Murine Model of Infection. Infect. Immun.
71: 1405-1415
[Abstract]
[Full Text]
-
Gronow, S., Noah, C., Blumenthal, A., Lindner, B., Brade, H.
(2003). Construction of a Deep-rough Mutant of Burkholderia cepacia ATCC 25416 and Characterization of Its Chemical and Biological Properties. J. Biol. Chem.
278: 1647-1655
[Abstract]
[Full Text]
-
Kawahara, K., Tsukano, H., Watanabe, H., Lindner, B., Matsuura, M.
(2002). Modification of the Structure and Activity of Lipid A in Yersinia pestis Lipopolysaccharide by Growth Temperature. Infect. Immun.
70: 4092-4098
[Abstract]
[Full Text]